7Baggers

Enfusion, Inc.
(NYSE:ENFN) 

ENFN stock logo

Enfusion Inc. offers software-as-a-service for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools, which a...

Founded: 1995
CEO: Thomas Kim  
Sector: Technology
Industry: Software—Application

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
                  
      revenues:
                  
      platform subscriptions
    49,252,000 47,786,000 45,794,000 44,689,000 43,054,000 40,857,000 39,610,000 37,998,000 37,804,000 35,953,000 33,560,000 31,551,000 28,936,000 27,136,000 
      managed services
    3,211,000 3,078,000 3,223,000 3,177,000 3,056,000 3,028,000 2,945,000 2,744,000 2,691,000 2,504,000 2,396,000 2,230,000 1,935,000 1,890,000 
      other
    475,000 302,000 438,000 186,000 376,000 472,000 166,000 229,000 22,000 694,000 584,000 360,000 982,000 19,000 
      total revenues
    52,938,000 51,166,000 49,455,000 48,052,000 46,486,000 44,357,000 42,721,000 40,971,000 40,517,000 39,151,000 36,540,000 34,141,000   
      yoy
    13.88% 15.35% 15.76% 17.28% 14.73% 13.30% 16.92% 20.01%       
      qoq
    3.46% 3.46% 2.92% 3.37% 4.80% 3.83% 4.27% 1.12% 3.49% 7.15% 7.03%    
      ​
                  
      cost of revenues:
                  
      total cost of revenues
    16,398,000 16,340,000 15,962,000 16,174,000 15,624,000 14,507,000 14,208,000 13,302,000 13,296,000 11,974,000 10,847,000 10,983,000 10,164,000 8,095,000 
      gross profit
    36,540,000 34,826,000 33,493,000 31,878,000 30,862,000 29,850,000 28,513,000 27,669,000 27,221,000 27,177,000 25,693,000 23,158,000 21,689,000 20,950,000 
      yoy
    18.40% 16.67% 17.47% 15.21% 13.38% 9.84% 10.98% 19.48% 25.51% 29.72%     
      qoq
    4.92% 3.98% 5.07% 3.29% 3.39% 4.69% 3.05% 1.65% 0.16% 5.78% 10.95% 6.77% 3.53%  
      gross margin %
    69.02% 68.06% 67.72% 66.34% 66.39% 67.29% 66.74% 67.53% 67.18% 69.42% 70.31% 67.83% Infinity% Infinity% 
      operating expenses:
                  
      general and administrative
    21,148,000 18,782,000 18,673,000 20,223,000 17,115,000 16,721,000 16,326,000 14,473,000 15,073,000 13,094,000 18,302,000 22,295,000 128,229,000 8,546,000 
      sales and marketing
    6,570,000 6,221,000 6,021,000 6,217,000 5,552,000 5,503,000 5,277,000 4,086,000 6,001,000 7,278,000 7,575,000 8,432,000 39,402,000 4,901,000 
      technology and development
    7,238,000 6,842,000 6,096,000 6,551,000 6,061,000 4,937,000 4,464,000 4,431,000 4,775,000 3,864,000 3,722,000 4,802,000 146,556,000 2,600,000 
      total operating expenses
    34,956,000 31,845,000 30,790,000 32,991,000 28,728,000 27,161,000 26,067,000 22,990,000 25,849,000 24,236,000 29,599,000 35,529,000 314,187,000 16,047,000 
      income from operations
    1,584,000 2,981,000 2,703,000 -1,113,000 2,134,000 2,689,000 2,446,000 4,679,000 1,372,000 2,941,000 -3,906,000 -12,371,000 -292,498,000 4,903,000 
      yoy
    -25.77% 10.86% 10.51% -123.79% 55.54% -8.57% -162.62% -137.82% -100.47% -40.02%     
      qoq
    -46.86% 10.28% -342.86% -152.16% -20.64% 9.93% -47.72% 241.03% -53.35% -175.29% -68.43% -95.77% -6065.69%  
      operating margin %
    2.99% 5.83% 5.47% -2.32% 4.59% 6.06% 5.73% 11.42% 3.39% 7.51% -10.69% -36.24% -Infinity% Infinity% 
      non-operating income:
                  
      payment to related party
          -1,501,000        
      loss on extinguishment of debt
        -19,500 -78,000         
      interest income
    533,000 487,000 356,000 317,000           
      other income
    -200,000 -607,000   267,250 417,000 241,000 411,000 -590,000 -52,000 1,000 3,000 -1,214,000 29,000 
      total non-operating income
    874,000 -120,000 245,000 235,000 46,000 339,000 -1,260,000 411,000    -3,000 -1,521,000 -1,456,000 
      income before income taxes
    2,458,000 2,861,000 2,948,000 -878,000 2,180,000 3,028,000 1,186,000 5,090,000 1,206,000 2,885,000 -3,906,000 -12,374,000 -294,019,000 3,447,000 
      income taxes
    2,286,000 904,000 401,000 -117,000 1,280,000 367,000 188,000 396,000 418,000 287,000 219,000 150,000 176,000 154,000 
      net income
    172,000 1,957,000 2,547,000 -761,000 900,000 2,661,000 998,000 4,694,000 788,000 2,598,000 -4,125,000 -12,524,000 -293,894,000 3,293,000 
      yoy
    -80.89% -26.46% 155.21% -116.21% 14.21% 2.42% -124.19% -137.48% -100.27% -21.11%     
      qoq
    -91.21% -23.16% -434.69% -184.56% -66.18% 166.63% -78.74% 495.69% -69.67% -162.98% -67.06% -95.74% -9024.81%  
      net income margin %
    0.32% 3.82% 5.15% -1.58% 1.94% 6.00% 2.34% 11.46% 1.94% 6.64% -11.29% -36.68% -Infinity% Infinity% 
      net income attributable to non-controlling interests
    51,000 542,000 721,000 -222,000 277,000 833,000 369,000 1,749,000 294,000 1,059,000     
      net income attributable to enfusion, inc.
    121,000 1,415,000 1,826,000 -539,000 623,000 1,828,000 629,000 2,945,000 494,000 1,539,000 -2,422,000    
      net income per class a common shares attributable to enfusion, inc.:
                  
      basic
     20 20 -10 10 20 10 40 -27.5 20     
      diluted
     20 20 -10 10 20 10 40 -27.5 20     
      weighted-average number of class a common shares outstanding:
                  
      basic
    92,045,000 92,904,000 91,480,000 89,509,000 88,202,000 87,739,000 88,314,000 88,863,000  85,156,000     
      diluted
    129,550,000 128,984,000 128,852,000 89,509,000 129,429,000 127,841,000 129,856,000 132,346,000  131,760,000     
      other expense
      -111,000 -82,000           
      interest expense
            -2,750 -4,000 -1,000 -6,000 -307,000 -1,485,000 
      total non-operating expense
            -166,000 -56,000     
      net loss attributable to non-controlling interests
              -1,703,000 -5,259,000   
      net loss per class a common shares attributable to enfusion, inc.:
                  
      basic and diluted
              -30 -100   
      weighted-average number of class a common shares outstanding:
                  
      basic and diluted
            85,393,000  84,581,000 83,384,000 83,045,000  
      net loss attributable to enfusion, inc.
               -7,265,000   
      total net revenues
                19,961,750 29,045,000 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
                    
        assets
                    
        current assets:
                    
        cash and cash equivalents
      54,480,000 48,299,000 34,447,000 32,894,000 35,604,000 31,652,000 27,771,000 54,598,000 62,545,000 63,543,000     
        accounts receivable
      31,988,000 32,173,000 33,672,000 30,932,000 28,069,000 24,855,000 25,170,000 24,356,000 25,855,000 28,992,000 28,771,000 23,410,000 18,223,000 18,999,000 
        prepaid expenses
      5,342,000 3,576,000 4,475,000 5,420,000 5,009,000 4,079,000 4,967,000 5,600,000 6,105,000 2,605,000 3,634,000 5,458,000   
        other current assets
      1,711,000 1,388,000 1,573,000 1,677,000 1,170,000 1,459,000 1,718,000 2,093,000 2,303,000 888,000 1,287,000 1,332,000   
        total current assets
      93,521,000 85,436,000 74,167,000 70,923,000 69,852,000 62,045,000 59,626,000 86,647,000 96,808,000 96,028,000 90,251,000 86,406,000 89,678,000 35,508,000 
        notes receivable
      3,000,000 3,000,000 3,000,000            
        property, equipment, and software
      20,963,000 20,513,000 19,672,000 18,851,000 18,314,000          
        right-of-use-assets
      18,062,000 18,926,000 16,054,000 14,151,000 14,304,000 15,734,000 12,388,000 13,438,000       
        other assets
      7,715,000 7,065,000 7,197,000 7,038,000 6,502,000 5,825,000 4,532,000 4,529,000 4,484,000 4,151,000 3,783,000 3,499,000 3,356,000 1,625,000 
        total assets
      143,261,000 134,940,000 120,090,000 110,963,000 108,972,000 101,740,000 94,053,000 121,493,000 123,783,000 115,602,000 110,127,000 104,951,000 106,085,000 49,631,000 
        ​
                   2,021,000 
        liabilities and stockholders’ equity
                    
        current liabilities:
                    
        accounts payable
      867,000 1,175,000 816,000 3,364,000 2,212,000 1,341,000 868,000 1,290,000 1,685,000 1,185,000 879,000 1,189,000 2,528,000 2,309,000 
        accrued expenses and other current liabilities
      20,393,000 16,460,000 11,862,000 9,513,000 13,841,000 10,629,000 8,129,000 7,403,000 11,665,000 10,804,000 8,963,000 6,557,000 5,578,000 8,968,000 
        current portion of lease liabilities
      6,076,000 5,935,000 5,194,000 4,529,000 4,256,000 4,403,000 4,761,000 5,013,000 4,030,000      
        total current liabilities
      27,336,000 23,570,000 17,872,000 17,406,000 20,309,000 16,373,000 13,758,000 13,706,000 17,380,000 11,989,000 9,842,000 7,746,000 8,106,000 16,277,000 
        lease liabilities, net of current portion
      14,236,000 15,193,000 12,803,000 10,931,000 11,181,000 12,090,000 8,052,000 8,642,000 2,959,000      
        other non-current liabilities
      2,150,000              
        total liabilities
      43,722,000 38,763,000 30,675,000 28,337,000 31,490,000 28,463,000 21,810,000 22,348,000 20,339,000 12,432,000 10,321,000 8,243,000 8,644,000 109,400,000 
        commitment and contingencies
                    
        stockholders’ equity:
                    
        preferred stock, 0.001 par value...
                    
        class a common stock, 0.001 par value...
      95,000 93,000 92,000 90,000 88,000 88,000 82,000 74,000 71,000 67,000 67,000 66,000 66,000  
        class b common stock, 0.001 par value...
      34,000 35,000 36,000 38,000 39,000 39,000 41,000 41,000 43,000 46,000 46,000 47,000 47,000  
        additional paid-in capital
      243,935,000 240,224,000 236,327,000 231,881,000 226,877,000 224,710,000 223,766,000 240,075,000 244,260,000 241,045,000 240,501,000 233,607,000 226,717,000  
        accumulated deficit
      -170,109,000 -170,230,000 -171,645,000 -173,471,000 -172,932,000 -173,555,000 -175,383,000 -176,012,000 -178,863,000 -179,357,000 -180,896,000 -178,474,000 -171,209,000  
        accumulated other comprehensive loss
      -734,000 -199,000 -509,000 -484,000 -406,000 -548,000 -378,000 -473,000 -504,000 -672,000 -582,000 -375,000 -325,000 -306,000 
        total stockholders’ equity attributable to enfusion, inc.
      73,221,000 69,923,000 64,301,000 58,054,000 53,666,000 50,734,000 48,128,000 63,705,000 65,007,000 61,129,000 59,136,000 54,871,000   
        non-controlling interests
      26,318,000 26,254,000 25,114,000 24,572,000 23,816,000 22,543,000 24,115,000 35,440,000 38,437,000 42,041,000 40,670,000 41,837,000 42,145,000  
        total stockholders’ equity
      99,539,000 96,177,000 89,415,000 82,626,000 77,482,000 73,277,000         
        total liabilities and stockholders’ equity
      143,261,000 134,940,000 120,090,000 110,963,000 108,972,000 101,740,000         
        property and equipment
           18,136,000 17,507,000 16,879,000 15,759,000 15,423,000 16,093,000 15,046,000 13,051,000 12,498,000 
        liabilities and stockholders' equity
                    
        stockholders' equity:
                    
        total stockholders' equity
            72,243,000 99,145,000 103,444,000 103,170,000 99,806,000 96,708,000   
        total liabilities and stockholders' equity
            94,053,000 121,493,000 123,783,000 115,602,000 110,127,000 104,951,000   
        right-of-use assets
              6,732,000      
        other liabilities
               443,000 479,000 497,000 538,000 588,000 
        cash
                56,559,000 56,206,000 64,365,000 8,432,000 
        commitments and contingencies
                    
        prepaid expenses and other current assets
                  7,090,000 8,077,000 
        liabilities, preferred units, stockholders' equity and members’ deficit
                    
        current portion of long-term debt
                   5,000,000 
        long-term debt
                   92,535,000 
        preferred units:
                    
        class c-1 units, no par value, 28.777 units issued and outstanding as of december 31, 2020
                    
        class c-2 units, no par value, 12.219 units issued and outstanding as of december 31, 2020
                    
        class d units, no par value, 12.778 units issued and outstanding as of december 31, 2020
                    
        total preferred units
                   169,866,000 
        stockholders' equity/members’ deficit:
                    
        members' deficit, no par value, 47.968 units issued and outstanding as of december 31, 2020
                    
        preferred stock, par value 0.001 per share...
                    
        total stockholders’ equity attributable to enfusion, inc. /members’ deficit
                  55,296,000  
        total stockholders' equity/ members’ deficit
                  97,441,000  
        total liabilities, preferred units and stockholders’ equity/members’ deficit
                  106,085,000  
        liabilities, preferred units and members’ equity
                    
        class c-1 units, no par value, 28.777 units issued and outstanding as of september 30, 2021 and december 31, 2020.
                   8,901,000 
        class c-2 units, no par value, 12.219 units issued and outstanding as of september 30, 2021 and december 31, 2020.
                   45,900,000 
        class d units, no par value, 12.778 units issued and outstanding as of september 30, 2021 and december 31, 2020.
                   115,065,000 
        members’ equity
                    
        class a units, no par value, 47.968 units issued and outstanding as of september 30, 2021 and december 31, 2020.
                   -229,329,000 
        total members’ equity
                   -229,635,000 
        total liabilities, preferred units and members’ equity
                   49,631,000 
        revenues:
                    
        platform subscriptions
                   27,136,000 
        managed services
                   1,890,000 
        other
                   19,000 
        total net revenues
                   29,045,000 
        cost of revenues:
                    
        total cost of revenues
                   8,095,000 
        gross profit
                   20,950,000 
        operating expenses:
                    
        general and administrative
                   8,546,000 
        sales and marketing
                   4,901,000 
        technology and development
                   2,600,000 
        total operating expenses
                   16,047,000 
        income from operations
                   4,903,000 
        non-operating income:
                    
        interest expense
                   -1,485,000 
        other income
                   29,000 
        total non-operating income
                   -1,456,000 
        income before income taxes
                   3,447,000 
        income taxes
                   154,000 
        net income
                   3,293,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 
                     
          cash flows from operating activities:
                     
          net income
        172,000 1,957,000 2,547,000 -761,000 900,000 2,661,000 998,000 4,694,000 788,000 2,598,000 -4,125,000 -12,524,000 -293,894,000 
          adjustments to reconcile net income to net cash from operating activities:
                     
          non-cash lease expense
        1,829,000 1,752,000 2,037,000 1,765,000 1,651,000 1,975,000        
          depreciation and amortization
        3,247,000 2,960,000 2,873,000 2,674,000 3,515,000 2,522,000 2,082,000 1,868,000 1,690,000 1,699,000 1,615,000 1,340,000 1,316,000 
          provision for credit losses
          410,000 -141,000 -71,000 702,000 213,000 475,000      
          amortization of debt-related costs
        58,000 59,000 58,000 59,000 75,000 4,000 7,000 6,000 7,000 6,000 7,000 6,000 
          loss on extinguishment of debt
                    
          stock-based compensation expense
        3,733,000 4,198,000 4,101,000 7,001,000 3,404,000 2,623,000 2,578,000 -1,147,000 4,205,000 438,000 7,668,000 12,682,000  
          change in operating assets and liabilities:
                     
          accounts receivable
        -123,000 1,854,000 -3,156,000 -2,722,000 -3,141,000 -390,000 -1,026,000 878,000 2,999,000 -1,023,000 -5,697,000 -5,310,000 -396,000 
          prepaid expenses and other assets
            -1,828,000 509,000 723,000 -1,153,000     -972,000 
          accounts payable
        -306,000 382,000 -2,572,000 1,311,000 707,000 475,000 -422,000 -395,000 540,000 587,000 -631,000 -1,339,000 219,000 
          accrued compensation
        2,393,000 2,926,000 1,901,000 -3,545,000 1,462,000 1,790,000        
          accrued expenses and other liabilities
        1,603,000 1,244,000 283,000 -455,000 1,197,000 787,000 4,637,000 -4,262,000 910,000 1,805,000 2,388,000 938,000 -4,275,000 
          lease liabilities
        -1,778,000 -1,491,000 -1,402,000 -1,593,000 -1,269,000 -1,646,000        
          other non-current liabilities
                     
          net cash from operating activities
        9,673,000 16,162,000 7,314,000 1,533,000 6,586,000 12,106,000 6,018,000 924,000 7,521,000    -5,812,000 
          capital expenditures
        -891,000 -1,104,000 -1,005,000 -635,000 2,923,000 -2,607,000 -2,219,000 -2,550,000 -1,746,000    -1,641,000 
          free cash flows
        8,782,000 15,058,000 6,309,000 898,000 9,509,000 9,499,000 3,799,000 -1,626,000 5,775,000    -7,453,000 
          cash flows from investing activities:
                     
          purchases of property and equipment
        -891,000 -1,104,000 -1,005,000 -635,000 2,923,000 -2,607,000 -2,219,000 -2,550,000 -1,746,000 -922,000 -2,092,000 -3,171,000 -1,641,000 
          capitalization of software development costs
        -1,772,000 -1,671,000 -1,701,000 -2,113,000          
          purchase of convertible promissory note
                   
          net cash from investing activities
        -2,663,000 -2,775,000 -5,706,000 -2,748,000 -2,295,000 -2,607,000 -2,219,000 -2,550,000 -1,746,000 -922,000 -2,092,000 -3,171,000 -1,641,000 
          cash flows from financing activities:
                     
          distributions to non-controlling interests
        -35,000 -101,000          
          settlement of tax receivable acquired in reorganization transactions
                    
          issuance of class a common stock, net of issuance costs
            7,630,000        
          payment of withholding taxes on stock-based compensation
        -14,000 19,000 -1,272,000 -579,000 -11,788,000 -40,501,000 -7,579,000 -7,042,000 -20,000 -92,000 -805,000  
          payment of debt issuance and debt facility costs
                     
          other financing activities
                    
          net cash from financing activities
        -14,000 -16,000 -1,373,000 -579,000 -5,309,000 -30,842,000 -6,353,000 -7,042,000 -20,000 -92,000 -805,000 63,382,000 
          effect of exchange rate changes on cash and cash equivalents
        -829,000 479,000 -39,000 -122,000 240,000 -309,000        
          net increase in cash and cash equivalents
        6,181,000             
          cash and cash equivalents, beginning of period
        35,604,000 62,545,000     
          cash and cash equivalents, end of period
        6,181,000 13,852,000 1,553,000 32,894,000 3,952,000 3,881,000 -26,827,000 54,598,000 -998,000     
          supplemental disclosure of cash flow information:
                     
          income taxes paid in cash
        1,205,000 307,000 166,000 372,000 1,245,000 260,000 133,000 205,000 529,000 720,000 68,000 265,000  
          supplemental disclosure of non-cash activities:
                     
          right-of-use assets obtained in exchange for lease liabilities
        3,752,000 1,150,000 3,661,000 1,318,000 5,355,000        
          capitalized stock-based compensation expense
        186,000 197,000 190,000 389,000 275,000 220,000 162,000 109,000 100,000     
          accrued property, equipment, and software
        186,000 257,000 189,000 168,000          
          provision for credit (benefit) losses
                     
          other operating activities
                     
          prepaid expenses
         907,000 947,000 -414,000          
          other assets
         -233,000 -713,000 -1,646,000          
          net decrease in cash and cash equivalents
          1,553,000 -2,710,000  3,881,000        
          payment of debt issuance costs
                     
          repayment of term loan
                    -98,750,000 
          payment of member distributions
                    
          purchases of common units from pre-ipo common unit holders
                     
          interest paid in cash
                     
          effect of the reorganization transactions
                     
          ipo costs included in accrued expenses and other liabilities
                     
          other
              -33,000 -275,000      
          supplemental disclosure of non-cash investing activities:
                     
          accrued property and equipment
                     
          settlement of tax receivable acquired in reorganization transaction
              1,501,000      
          non-cash operating lease expense
               -40,000      
          effect of exchange rate changes on cash
               32,000 269,000 84,000 -353,000 -86,000 4,000 
          net decrease in cash
               -7,947,000  6,984,000 353,000 -8,159,000  
          cash paid for amounts included in the measurement of lease liabilities
               1,478,000      
          ​
                     
          provision for bad debts
                138,000 802,000 336,000 123,000 1,172,000 
          net foreign currency losses
                     
          prepaid expenses and other current assets
                -4,013,000 930,000 1,329,000 -13,000  
          proceeds from term loan
                     
          issuance of class d units, net of issuance costs
                     
          proceeds from draw on revolving debt facility
                     
          redemption of class a units
                     
          distribution of loan proceeds to members
                     
          repayment of draw on revolving debt facility
                     
          payment of equity issuance costs on non-cash issuance of class d units
                     
          issuance of class a common stock in the ipo, net of issuance costs
                     
          supplemental disclosure of non-cash financing activities:
                     
          issuance of class d units in a non-cash exchange for class c-1 and c-2 units
                     
          accrued property, plant and equipment
                 -281,000    
          net cash (used) provided by operating activities
                  2,890,000 -4,097,000  
          cash, beginning of period
                  64,365,000 
          cash, end of period
                  353,000 56,206,000 55,933,000 
          issuance of class c-2 units, net of issuance costs
                     
          purchase of common units from pre-ipo common unit holders
                     
          net increase in cash
                    55,933,000 
          interest paid